Completed PHASE4 INTERVENTIONAL 2-arm NCT01822483

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (AUC-MPA)

Sponsor: Irmandade Santa Casa de Misericórdia de Porto Alegre

Interventions Mycophenolate mofetil Mycophenolate sodium

Updated 6 times since 2017 Last updated: Apr 1, 2015 Started: Apr 30, 2013 Primary completion: Mar 31, 2015 Completion: Mar 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Renal Transplantation, this trial is completed. The trial is conducted by Irmandade Santa Casa de Misericórdia de Porto Alegre and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Data source: Irmandade Santa Casa de Misericórdia de Porto Alegre

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Porto Alegre, Brazil